Kaizen Oncology Private Limited
About Kaizen Oncology Private Limited
Data last updated:
Kaizen Oncology Private Limited is a private limited company based in Hyderabad, Telangana, India. It was incorporated on 16 March 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U86100TS2023PTC171156.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepak Koppaka and Yugandar Reddy Yenkekalya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.75 Cr. For the same year it recorded a net profit of ₹64.39 Lakh (net margin 3.8%) and EBITDA of ₹86.04 Lakh (EBITDA margin 5.1%).
Company details
Contact details
Kaizen Oncology Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No. 62/A Panchavati Colony, Manikonda Puppalaguda, Hyderabad, Telangana, India – 500089
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kaizen Oncology Private Limited
FY 2025 filings availableKaizen Oncology Private Limited reported revenue of ₹16.75 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹86.04 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹64.39 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.1% | ||
| Net Profit Margin | 3.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Kaizen Oncology Private Limited, buy the company report.
Board of directors of Kaizen Oncology Private Limited
Kaizen Oncology has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Koppaka Also directs: Ninaad Healthcare Foundation | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Yugandar Reddy Yenkekalya Also directs: Ninaad Healthcare Foundation | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Sudha Sinha Also directs: Ninaad Healthcare Foundation | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Sathish Pawar | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Kaizen Oncology Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Oncology Care), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kims Cancer Care and Research Center Private Limited | ₹20.62 Cr (FY 2018) | -2.0% | Thiruvananthapuram, Kerala, India | |||
| Optimus Oncology Private Limited | ₹19.67 Cr (FY 2025) | 12.0% | Nashik, Maharashtra, India | |||
| North East Onco Care Private Limited | ₹19.33 Cr (FY 2025) | -10.0% | Guwahati, Assam, India | |||
| Radon Oncology Private Limited | ₹18.56 Cr (FY 2025) | 9.0% | Hubli, Karnataka, India | |||
| Sky Oncology LLP | ₹18.06 Cr (FY 2025) | 283.0% | Thane, Maharashtra, India | |||
| Kaizen Oncology Private Limitedthis company | ₹16.75 Cr (FY 2025) | ₹64.39 Lakh | 3.8% | Hyderabad, Telangana, India | ||
| 4Basecare Precision Health Private Limited | ₹14.27 Cr (FY 2025) | Bangalore, Karnataka, India | ||||
| DKMS BMST Foundation India | ₹14.12 Cr (FY 2025) | -24.0% | Bangalore, Karnataka, India | |||
| Synergy Institute of Cancer Care and Research Private Limited | ₹14.03 Cr (FY 2025) | 73.0% | Gorakhpur, Uttar Pradesh, India | |||
| Aaruni Hospital Privtae Limited | ₹13.78 Cr (FY 2025) | -16.0% | Rajkot, Gujarat, India | |||
| Um Cancer Care and Research Center Private Limited | ₹13.12 Cr (FY 2025) | 48.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Kaizen Oncology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kaizen Oncology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kaizen Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kaizen Oncology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kaizen Oncology Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Deepak Koppaka was appointed as Director on 16 Mar 2023.
Frequently asked questions
Kaizen Oncology is an active private limited company based in Hyderabad, Telangana, India. It was incorporated on 16 March 2023 (3+ years old) and is registered under CIN U86100TS2023PTC171156.
Kaizen Oncology has 4 current directors:
- Deepak Koppaka - Director
- Yugandar Reddy Yenkekalya - Director
- Sudha Sinha - Director
- Sathish Pawar - Director
The latest financial statements of Kaizen Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Kaizen Oncology is U86100TS2023PTC171156. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kaizen Oncology was incorporated on 16 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Kaizen Oncology by revenue are Kims Cancer Care and Research Center Private Limited, Optimus Oncology Private Limited, North East Onco Care Private Limited, Radon Oncology Private Limited, Sky Oncology LLP and 5 more, all in the Healthcare industry (Oncology Care).
Deepak Koppaka was appointed as Director on 16 Mar 2023. Sathish Pawar was appointed as Director on 16 Mar 2023. Sudha Sinha was appointed as Director on 16 Mar 2023. Kaizen Oncology has 4 board changes on record in total.
The registered office of Kaizen Oncology is at Plot No. 62A Panchavati Colony, Manikonda Puppalaguda, Hyderabad, Telangana, India – 500089.
Kaizen Oncology can be reached at its registered office: Plot No. 62A Panchavati Colony, Manikonda Puppalaguda, Hyderabad, Telangana, India – 500089.
Kaizen Oncology is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
